We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-2.91%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$14.1B
AUM Growth
+$741M
(+5.6%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
11.22%
Top 10 Holdings %
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49
Avg Time Held
14.1
quarters
Top 10 Avg Time Held
19
quarters
Top 20 Avg Time Held
14.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$110M |
| 2 |
Apple
AAPL
|
+$89M |
| 3 |
Microsoft
MSFT
|
+$81.1M |
| 4 |
Amazon
AMZN
|
+$54.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$45.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$4.8M |
| 2 |
KeyCorp
KEY
|
+$4.08M |
| 3 |
Solstice Advanced Materials
SOLS
|
+$3.06M |
| 4 |
Valero Energy
VLO
|
+$2.61M |
| 5 |
Monster Beverage
MNST
|
+$2.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.95% |
| 2 | Financials | 11.04% |
| 3 | Consumer Discretionary | 10.62% |
| 4 | Communication Services | 10.59% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1626
DELISTED
Esperion Therapeutics
ESPR
| $57.5K | ﹤0.01% |
20,974
+2,888
| +16% | +$9.14K |
2024 Q2
7 quarters
|
|
1627
indie Semiconductor
INDI
$580M
| $57.3K | ﹤0.01% |
17,796
+2,399
| +16% | +$8.47K |
2024 Q2
7 quarters
|
|
1628
FTAI Infrastructure
FIP
$307M
| $56.5K | ﹤0.01% |
11,447
+1,254
| +12% | +$7.02K |
2025 Q4
1 quarter
|
|
1629
Gevo
GEVO
$324M
| $56.2K | ﹤0.01% |
20,601
+2,805
| +16% | +$5.81K |
2025 Q2
3 quarters
|
|
1630
UWM Holdings
UWMC
$369M
| $54.7K | ﹤0.01% |
15,117
+4,611
| +44% | +$21.2K |
2025 Q4
1 quarter
|
|
1631
Hertz
HTZ
$667M
| $53.8K | ﹤0.01% |
11,681
+1,243
| +12% | +$6.01K |
2025 Q1
4 quarters
|
|
1632
Ironwood Pharmaceuticals
IRWD
$623M
| $50.3K | ﹤0.01% |
14,337
+1,918
| +15% | +$7.86K |
2024 Q4
5 quarters
|
|
1633
Rezolve AI
RZLV
$750M
| $48.8K | ﹤0.01% |
19,068
+5,049
| +36% | +$14.2K |
2025 Q3
2 quarters
|
|
1634
Sabre
SABR
$763M
| $48.1K | ﹤0.01% |
33,167
+3,941
| +13% | +$5.25K |
2020 Q2
23 quarters
|
|
1635
Banco Bradesco
BBD
$45B
| $46.5K | ﹤0.01% |
+12,734
| New | +$48.3K |
2026 Q1
0 quarters
|
|
1636
Cytek Biosciences
CTKB
$693M
| $46.3K | ﹤0.01% |
+10,593
| New | +$50K |
2026 Q1
0 quarters
|
|
1637
AMC Entertainment Holdings
AMC
$2.61B
| $45.9K | ﹤0.01% |
46,830
+5,946
| +15% | +$7.65K |
2024 Q2
7 quarters
|
|
1638
NioCorp Developments
NB
$496M
| $45.8K | ﹤0.01% |
+10,278
| New | +$58.9K |
2026 Q1
0 quarters
|
|
1639
Solid Power
SLDP
$527M
| $45.7K | ﹤0.01% |
15,244
+3,347
| +28% | +$13.5K |
2024 Q3
6 quarters
|
|
1640
FerroAtlántica
GSM
$764M
| $43.9K | ﹤0.01% |
+10,659
| New | +$51.4K |
2026 Q1
0 quarters
|
|
1641
Sana Biotechnology
SANA
$817M
| $43.4K | ﹤0.01% |
15,080
+2,012
| +15% | +$7.92K |
2025 Q2
3 quarters
|
|
1642
Opko Health
OPK
$1.02B
| $42.5K | ﹤0.01% |
37,294
+4,933
| +15% | +$6.07K |
2021 Q2
19 quarters
|
|
1643
MiMedx Group
MDXG
$686M
| $42.4K | ﹤0.01% |
+10,723
| New | +$54K |
2026 Q1
0 quarters
|
|
1644
Brandywine Realty Trust
BDN
$453M
| $42.3K | ﹤0.01% |
15,621
+2,065
| +15% | +$6.18K |
2023 Q2
11 quarters
|
|
1645
Clean Energy Fuels
CLNE
$322M
| $38.7K | ﹤0.01% |
15,622
+2,084
| +15% | +$4.86K |
2023 Q3
10 quarters
|
|
1646
Bit Digital
BTBT
$451M
| $37.8K | ﹤0.01% |
28,828
+3,858
| +15% | +$7.08K |
2025 Q2
3 quarters
|
|
1647
Absci
ABSI
$1.68B
| $36.5K | ﹤0.01% |
12,160
+1,635
| +16% | +$4.73K |
2025 Q4
1 quarter
|
|
1648
iHeartMedia
IHRT
$297M
| $36.2K | ﹤0.01% |
12,398
+1,459
| +13% | +$4.83K |
2025 Q4
1 quarter
|
|
1649
Kopin
KOPN
$768M
| $35.2K | ﹤0.01% |
15,661
+2,047
| +15% | +$4.96K |
2025 Q2
3 quarters
|
|
1650
PowerFleet Inc
AIOT
$353M
| $34.5K | ﹤0.01% |
+11,186
| New | +$46.9K |
2026 Q1
0 quarters
|
|
Similar funds
PCM
LPC
MFG
PAM
BS
BBVA
NMO
PAS
Xponance's Q1 2026 Portfolio in Review
As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.
- Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
- Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
- Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
- Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
- Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
- Xponance opened 165 new positions and closed 49 in Q1 2026.
- Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.